Bustamante, Ricky D.

HRN: 09-06-19  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/08/2024
CEFTRIAXONE 1G (VIAL)
05/08/2024
05/14/2024
IVT
2g
Q24
Fracture, Closed, D/3rd Humerus, Left Sec To MVA
Waiting Final Action 

Indication:  ProphylaxisEmpiric    Type of Infection:  Bone & Joint    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: